Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.

J Nutr Health Aging · 2009 · PMC12876263 · PMID 19262954

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A first study concentrating on follow-up of MCI patients converting to AD showed no significant differences in Aß plasma levels ( 10 ), while in one of the largest MCI follow-up studies ( 11 ) in which also early dementia cases were included, highly significant reductions in the plasma Aß42/Aß40 ratio and in Aß42 levels were reported.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.